As 2018 drew to a close, Congress passed a bill that finally legalized industrial hemp after years of prohibition. Among other things, the 2018 Farm Bill legalized the cultivation and sale of industrial hemp plus its extracts. Soon after, demand for a hemp extract called cannabidiol (“CBD”) boomed to immense heights, based mostly on claims that it had extensive medical benefits. Subsequent studies have found CBD to indeed be effective against everything from anxiety, stress, and insomnia to chronic pain and pediatric epilepsy.
While CBD has been proven to be effective against a wide range of medical conditions, does it have the ability to actually increase your lifespan? According to the results of a new study, hemp extract actually may be able to help you live longer. A study by Canopy Group Corporation concluded that worms that consume CBD had a longer lifespan compared to worms that didn’t. Consuming hemp-derived CBD increased the overall lifespan of the worms by 20% and their late-stage activities by 200%.
Additionally, the worms did not exhibit signs of prolonged lifespan toxicity, which refers to the negative side effects of sustained exposure to a stressor. However, note that these results were from an animal study, so more research, specifically on the effect of long-term CBD use by humans, is needed. Still, the fact that cannabidiol increased the worms’ lifespan by 20% without causing any chronic toxicity is impressive.
Nonetheless, translating the methods used in this study for human research will prove difficult. Since worms have a lifespan of only two to three weeks, researchers had enough time to monitor the worms and document how CBD affected their lifespans. On the other hand, humans have a much longer lifespan, making the prospect of studying the long-term effects of CBD consumption on their lifespan more daunting. Fortunately, human and worm genes are quite similar, so the preclinical model used by the Canadian Cannabis Grower’s Association can be used for human studies.
The researchers’ objective was to find out how long-term CBD use affected the worms, especially in regards to solubility, acute toxicity and stability. The researchers found continued CBD use to be safe from any acute toxicity, with none of the worms dying that were exposed to acute CBD. In fact, exposure to concentrated CBD had the opposite effect and extended their lifespans.
A separate study by the University of Bonn looked at the effect of CBD on the memory performance of older mice and found that cannabis had the ability to reverse aging in the brain. Future studies will be needed to concretely prove cannabis’ effect on patients with Alzheimer’s disease.
This research pointing to the potential of CBD to extend human life gives the innovative products of many cannabis companies added value. For example, California-based Grapefruit USA Inc. (OTCQB: GPFT) has technology that makes topically administered CBD more absorbable, thereby increasing the likelihood that a user will get maximum benefit from the cannabis compound.
NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.